Abstract
Inhaled corticosteroids (ICSs) are the mainstay of treatment in children with asthma. Recently, the efficacy and safety of intermittent ICS in the management of children with persistent asthma has been receiving a lot of attention. MIST trial suggests the effect of intermittent budesonide in preschool children with recurrent wheezing. TREXA study suggests an effectiveness and safety of intermittent ICS as rescue medication with SABA for children with mild asthma. We can expect the future studies which investigate the possibilities of effect and safety of intermittent ICSs use in the long-term management of mild asthma in children.
